↓ Skip to main content

PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells

Overview of attention for article published in BMC Cancer, February 2013
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells
Published in
BMC Cancer, February 2013
DOI 10.1186/1471-2407-13-80
Pubmed ID
Authors

Hao Liu, Abdul Qader Omer Al-aidaroos, Haihe Wang, Ke Guo, Jie Li, Hua Fei Zhang, Qi Zeng

Abstract

Phosphatase of regenerating liver-3 (PRL-3), a protein tyrosine phosphatase, is highly expressed in multiple human cancers and strongly implicated in tumor progression and cancer metastasis. However, the mechanisms by which PRL-3 promotes cancer cell migration, invasion, and metastasis are not very well understood. In this study, we investigated the contribution and molecular mechanisms of PRL-3 in ovarian cancer progression.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 34%
Student > Master 4 14%
Other 3 10%
Researcher 2 7%
Student > Bachelor 2 7%
Other 6 21%
Unknown 2 7%
Readers by discipline Count As %
Agricultural and Biological Sciences 12 41%
Biochemistry, Genetics and Molecular Biology 6 21%
Medicine and Dentistry 3 10%
Chemistry 2 7%
Nursing and Health Professions 2 7%
Other 2 7%
Unknown 2 7%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 February 2013.
All research outputs
#3,167,253
of 4,505,030 outputs
Outputs from BMC Cancer
#1,525
of 2,430 outputs
Outputs of similar age
#61,043
of 89,212 outputs
Outputs of similar age from BMC Cancer
#60
of 82 outputs
Altmetric has tracked 4,505,030 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,430 research outputs from this source. They receive a mean Attention Score of 2.4. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 89,212 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.